MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fimmu.2026.1811565

Медицинская библиотека · Frontiers in immunology · 2026

Sequential efgartigimod and ofatumumab for stiff-person syndrome: a case report illustrating a pathophysiology-informed strategy and literature review.

Yang Chenxi, Zhou Junqiu, Jiang Haishan

СтатьяКлинический случайОбзорПеревод в очереди

Аннотация

BACKGROUND

Stiff-person syndrome (SPS) is a rare, antibody-mediated autoimmune disorder of the central nervous system, most frequently associated with antibodies against glutamic acid decarboxylase 65 (GAD65). Management of patients with an insufficient response to conventional immunotherapy remains a clinical challenge.

CASE PRESENTATION: We report a 40-year-old woman with anti-GAD65 antibody-positive SPS. She experienced severe relapse and functional disability (modified Rankin Scale [mRS] score 4) despite plasma exchange and maintenance immunosuppression. We designed a sequential, mechanism-base regimen: the neonatal Fc receptor antagonist efgartigimod (3 cycles) was administered to rapidly reduce pathogenic IgG, followed by the anti-CD20 monoclonal antibody ofatumumab (2 cycles) to deplete B-cells and provide sustained immunomodulation.

RESULTS

This sequential strategy resulted in substantial and sustained clinical improvement (mRS score 4 to 1, Barthel Index 75 to 100) and a reduced clonazepam requirement despite persistently high anti-GAD65 antibody titers, demonstrating efficacy beyond mere antibody reduction. The regimen was well-tolerated with no significant adverse events.

CONCLUSION

This case provides preliminary clinical experience with a sequential efgartigimod-ofatumumab strategy in treatment-resistant SPS. This approach, which combines rapid antibody clearance with sustained B-cell suppression, not only affirms the role of ofatumumab in long-term immunomodulation but also highlights the potential synergy of sequential administration, warranting further investigation.

Для цитирования: Yang Chenxi, Zhou Junqiu, Jiang Haishan. Sequential efgartigimod and ofatumumab for stiff-person syndrome: a case report illustrating a pathophysiology-informed strategy and literature review.. Frontiers in immunology. 2026. DOI: 10.3389/fimmu.2026.1811565.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.